A Phase 2 Randomized, Investigator-Masked, Comparator-controlled Trial to Evaluate the Safety and Efficacy of NS2 Eye Drops in Patients With Anterior Uveitis

Trial Profile

A Phase 2 Randomized, Investigator-Masked, Comparator-controlled Trial to Evaluate the Safety and Efficacy of NS2 Eye Drops in Patients With Anterior Uveitis

Completed
Phase of Trial: Phase II

Latest Information Update: 17 May 2017

At a glance

  • Drugs ADX 102 (Primary)
  • Indications Anterior uveitis
  • Focus Therapeutic Use
  • Sponsors Aldeyra Therapeutics
  • Most Recent Events

    • 17 May 2017 According to an Aldeyra Therapeutics media release, data was presented at the Association for Research in Vision and Ophthalmology (ARVO) 2017 Annual Meeting.
    • 18 May 2016 Status changed from active, no longer recruiting to completed.
    • 09 May 2016 Results published in an Aldeyra Therapeutics media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top